key: cord-0708812-sm5w43m6
authors: Harvey, William T.; Davies, Vinny; Daniels, Rodney S.; Whittaker, Lynne; Gregory, Victoria; Hay, Alan J.; Husmeier, Dirk; McCauley, John W.; Reeve, Richard
title: A Bayesian approach to incorporate structural data into the mapping of genotype to antigenic phenotype of influenza A(H3N2) viruses
date: 2022-03-27
journal: bioRxiv
DOI: 10.1101/2022.03.26.485931
sha: e71b93b3368aa0addb51c8d50c8125f4cedc7102
doc_id: 708812
cord_uid: sm5w43m6

Surface antigens of pathogens are commonly targeted by vaccine-elicited antibodies but antigenic variability, notably in RNA viruses such as influenza, HIV and SARS-CoV-2, pose challenges for control by vaccination. For example, influenza A(H3N2) entered the human population in 1968 causing a pandemic and has since been monitored, along with other seasonal influenza viruses, for the emergence of antigenic drift variants through intensive global surveillance and laboratory characterisation. Statistical models of the relationship between genetic differences among viruses and their antigenic similarity provide useful information to inform vaccine development though accurate identification of causative mutations is complicated by highly correlated genetic signals that arise due to the evolutionary process. Here, using a sparse hierarchical Bayesian analogue of an experimentally validated model for integrating genetic and antigenic data, we identify the genetic changes in influenza A(H3N2) virus that underpin antigenic drift. We show that incorporating protein structural data into variable selection helps resolve ambiguities arising due to correlated signals, with the proportion of variables representing haemagglutinin positions decisively included, or excluded, increased from 59.8% to 72.4%. The accuracy of variable selection judged by proximity to experimentally determined antigenic sites was improved simultaneously. Structure-guided variable selection thus improves confidence in the identification of genetic explanations of antigenic variation and we also show that prioritising the identification of causative mutations is not detrimental to the predictive capability of the analysis. Indeed, incorporating structural information into variable selection resulted in a model that could more accurately predict antigenic assay titres for phenotypically-uncharactrised virus from genetic sequence. Combined, these analyses have the potential to inform choices of reference viruses, the targeting of laboratory assays, and predictions of the evolutionary success of different genotypes, and can therefore be used to inform vaccine selection processes.

Antigenic variation is a mechanism by which an infectious agent such as a virus or bacterium alters the proteins or carbohydrates exposed to the host immune system to allow escape from immunity conferred by prior infection with or vaccination against a related agent. Antigenic drift seen in influenza viruses is a prime example of this process. Human seasonal influenza epidemics are estimated to infect around 15% of the global population annually resulting in three to five million cases of severe illness and in the order of 290,000 to 650,000 deaths annually (1,2). Influenza viruses evolve rapidly, with the frequency of mutations being highest in the genes encoding the surface glycoproteins such that antigenic variants can emerge. Some antigenic variants may rise to dominance among circulating viruses due to strong immune-mediated positive selection favouring viruses that infect individuals previously immune due to prior infection or vaccination. Consequently, human seasonal influenza vaccines must be frequently updated to ensure the antigenic responses they elicit will be active against viruses in circulation.

Seasonal influenza epidemics are caused by viruses belonging to two influenza A subtypes, A(H1N1) and A(H3N2), and by influenza B viruses which are classified into antigenically distinct lineages, B/Victoria and B/Yamagata. Trivalent vaccines contain antigens based on the influenza A(H1N1) and A(H3N2) and the predominant influenza B lineage while quadrivalent compositions include antigens representative of both influenza B lineages. To monitor the genetic and antigenic evolution of human influenza viruses, the WHO coordinates the Global Influenza Surveillance and Response System (GISRS) collaborating with academic scientists and national public health organisations (3, 4) . Vaccine strain selection is based on the antigenic and genetic evolution of circulating influenza viruses throughout the year and recommendations are developed by representatives of the GISRS at twice-yearly vaccine composition meetings.

Within each of the influenza A subtypes and influenza B lineages that cause seasonal influenza epidemics, the global virus populations typically consist of several antigenically distinct groups of viruses. It takes around six months to develop, produce and deliver an updated influenza vaccine so strain selection decisions must be made up to nine months in advance of the period when influenza viruses will circulate in a forthcoming season. It is therefore necessary to understand the antigenic similarity of circulating viruses to current vaccine strains and vaccine candidates to predict which antigenic variants are most likely to circulate at high frequency in advance of a future influenza season, a task that benefits from predictive modelling (5) . Various approaches have demonstrated prediction of successful influenza lineages, from those emerging, with potential to inform vaccine virus selections (6) (7) (8) . One approach is to use the shape and branching pattern of haemagglutinin (HA) phylogenetic trees to track and extrapolate changes in genotype frequency (6) . Another approach is to predict lineage fitness using counts of amino acid substitutions inside and outside described antigenic sites as proxies for antigenic drift and reduced stability respectively (7) ; an approach that can be adapted to incorporate data from assays used to measure antigenic drift. Both the accuracy of and the reliance on such predictive models depend on an understanding of the indirect link between genotype and reproductive fitness in a partially immune population, a relationship that is informed by the more direct phenotypic consequences of genetic changes.

The antigenic characterisation of circulating viruses is dependent upon haemagglutination inhibition (HI) and virus neutralisation (VN) assays, both of which are used to assess the antigenic similarity of a circulating test virus to a panel of reference viruses that includes previous and current vaccine viruses and other candidate vaccine viruses. The panel of reference viruses, and post-infection ferret antisera raised against them, are selected to represent the diversity of antigenic phenotypes observed over the most recent seasons. Various modelling approaches have used data from antigenic assays to quantify similarity (9) , and to explore the relationship between genetic and antigenic evolution allowing predictions of antigenic relationships from sequence data (8, (10) (11) (12) . A general challenge for modelling genotype-phenotype relationships is differentiating causative mutations from those that are non-causative and correlate with phenotypic changes due to genetic hitchhiking. One technique to improve differentiation is to explicitly account for the shared evolutionary history of viruses. Various comparative methods already exist to account for shared evolutionary history, but these tend to focus on traits intrinsically associated with particular taxa rather than ones that relate to relationships between taxa, as is the case here when working with pairwise measures of antigenic similarity. However, by including terms that represent branches of the phylogenetic tree, it is possible to account for shared evolutionary history and to prevent false statistical support for genetic terms due to repeated measurements (13) .

Comparing sequences of test and reference viruses, while accounting for phylogenetic correlations, we have previously identified substitutions responsible for antigenic evolution among human influenza A(H1N1) and avian influenza A(H9N2) viruses (12, 14) . We then made this phylogenetically-aware model more statistically rigorous within a Bayesian framework with antigenic determinants identified using 'spikeand-slab' priors (15) , a method of variable selection (SABRE) demonstrated to outperform alternative approaches such as LASSO (16) and elastic net regularised regression (17) as well as our own previous work (12) . We further extended these approaches (eSABRE) by the inclusion of variables representing the underlying HI titre for each reference/test virus pair (18) . However, in order to allow us to fully characterise the algorithms involved, the data analysed in that study comprised only 43 viruses. These previous approaches can therefore be characterised as either applying methodologically-limited methods of model selection to datasets of scientific relevance (12) , or the application of state-of-the-art Bayesian approaches to datasets of limited scale and relevance to the problem of antigenically characterising viruses (18) .

Here we develop these techniques into a practical tool for antigenic characterisation of viruses using Bayesian stochastic search variable selection (BSSVS) within a hierarchical model structure applied to a large set of antigenic data spanning 25 years and consisting of over 38,000 individual antiserum titres derived using panels of antisera and contemporary circulating test viruses. The BSSVS approach for model selection, which allows us to identify the combination of genetic variables best explaining the observed antigenic variation, is performed within the model as it undergoes Markov chain Monte Carlo (MCMC) sampling. Variables under investigation are free to drop out and return to the model as the optimal combination of terms is converged upon. Consequently, parameter estimates are made averaging over the best set of models, allowing uncertainty in the optimal combination of variables to be accounted for directly. A further advantage of a Bayesian approach here is that existing knowledge can be used to define the prior distribution of parameters. These priors, together with the likelihood of the observed data given the statistical model, combine using standard Bayesian methods to form the posterior distribution of parameters. We show that information derived from measurements of solved protein structures can be used to shape prior distributions and improve the accuracy with which we can attribute changes in antigenic phenotype to causative amino acid substitutions. Finally, using Bayesian model averaging, where predictions are averaged over a range of the best supported models (19) , these approaches show the ability to accurately predict antigenic relationships from genetic sequences, whilst actively aiming to optimise variable selection.

The approach presented infers the genetic determinants of antigenic evolution by attributing variation in antigenic assays to differences in the amino acid sequences of reference and test viruses, while accounting for both phylogenetic structure in the data and other non-antigenic factors that cause variation in titres. Using fixed quantities of reference and test viruses, commonly eight or four haemagglutinating units in a particular HI assay, titres are recorded as the reciprocal of the maximum dilution of antiserum raised to a particular reference strain that is able to inhibit agglutination of red blood cells by a test virus. Lower titres, expressed as fold-drops, therefore reflect reduced antigenic similarity. The log2 titre is modelled reflecting the two-fold serial dilution of antiserum in assays. We describe below how the variation in titres attributable to the antigenic properties of viruses can be attributed to virus HA-gene sequences, firstly by mapping antigenic changes to branches of the phylogenetic tree and secondly by attributing antigenic changes to specific amino acid differences between reference and test viruses. Model selection was performed using BSSVS via binary indicator variables associated with each branch or amino acid position (18) . These indicator variables, also known as binary mask variables, take the value zero or one determining variable exclusion (masking) or inclusion, respectively. The optimal combination of branches, or amino acid positions at which substitutions explain antigenic changes, is therefore determined by sampling these binary mask variables using MCMC.

Throughout this approach, we model the assay titre measured for an antiserum raised against reference virus and each specific virus on a given date as lognormally distributed:

The log2 titre has a mean determined by combining the underlying log2 titre for each combination of reference virus and test virus, ",$ , and an effect accounting for day-to-day experimental variability in titres, % . The use of log2 reflects the use of a two-fold serial dilution of antiserum, with recorded titres being the reciprocals of these dilutions. Residual variance of measured titres around this mean is represented by & ! . To improve the succinctness and therefore clarity of this section, prior distributions and other implementation details are provided in the Model Implementation subsection of the Materials and Methods, and details of indices, parameters, variances and other minor terms are described in Table 1 .

The underlying log2 titre in Eq 1 is itself normally distributed:

Underlying titres are modelled as depending on three general characteristics of the assayed viruses and antisera. The contributions of effects for reference strain immunogenicity, " , test virus avidity, $ , and the antigenic relationship, Δ ",$ are each inferred. The immunogenicity and avidity terms reflect general reactivity of antisera and viruses respectively. These manifest as a trend for higher or lower titres against all viruses or antisera for which titres are measured, independent of antigenic relationships. The genetic determinants of this antigenic component is of principal interest, so in the remainder of this section we describe how variation in this term is attributed to differences in the HA protein (see Table 1 for further details on the other effects). Since antigenic differences between reference and test viruses manifest as lower titres, the antigenic component of the model is constrained to take only non-negative values and is subtracted from the other terms in the model. Δ ",$ is defined in several different ways in Eqs 3, 4, 5, 6 and 9, below, to allow us to compare different models of this antigenic relationship.

Antigenic difference is initially modelled as a linear combination of effects that occur during the phylogenetic evolution of the assayed viruses, with terms representing every branch, , of the phylogeny to which amino acid substitutions were mapped in an ancestral state reconstruction (see Materials and Methods), Ψ, tested as predictors of reduced HI titres:

For each branch, a precomputed indicator variable ( ( , ) is one when the branch falls on a direct path through the tree separating the reference and test viruses, and zero otherwise. Consequently, the titre for each combination of reference virus and test virus only depends on the antigenic weights for the combination of branches that fall between them on a path traced through the tree. The parameter ( is the antigenic weight associated with the branch, the expected drop in log2 HI titre when two viruses are The set of non-conserved amino acid positions Κ !

The set of observed substitutions at a specific amino acid position Ψ * = , ∈ Ψ: ̅ " > 4

The subset of the branches in Ψ inferred from Eqn 3, with probability > p, to map to antigenic changes Indicator variables The measured titre for an antiserum raised against a particular reference virus and a test virus on a particular date ),! , *,! Structural feature scores associated with an amino acid position (scaled to lie between zero and one)

Binary masks (determining whether a term is included in the model)

Binary mask determining whether to include (1) or mask (0) an antigenic term associated with a branch in the HA phylogeny (and its posterior mean) ! Binary mask determining whether to include or mask an antigenic term associated with an amino acid position (in a structurally-naïve model). = ! Binary mask determining whether to include or mask an antigenic term associated with an amino acid position (in a structurally-aware model). Test virus avidity effect that results in a tendency for higher or lower titres, which is attributed to differences in avidity for the virus receptors on the red blood cell Δ %, ' The antigenic difference between reference strain and test virus " Antigenic weight mapping to a specific branch # $ Antigenic effect of a specific substitution at an amino acid position D ! Component of antigenic effect ascribed to an amino acid position D′ # Component of antigenic effect ascribed to a specific amino acid substitution Probabilities Threshold posterior mean probability for identifying a branch as potentially mapping to an antigenic change from Eq 3 ( G)

Probability of branch being inferred to be antigenically important (and its posterior mean), prior for " $ ( $ H ) Structurally-naïve probability of any amino acid position being inferred to be antigenically important (and its posterior mean), prior for ! I ! ( I ! GGG ) Structure-informed probability of a specific amino acid position being inferred to be antigenically important (and its posterior mean), prior for = ! Powers ) , * Power terms control importance of structural features in calculating I ! Variances + * Residual variance of data around underlying titre and date effect , * Variance of underlying titres around modelled effects separated in the phylogeny by branch . The binary mask variable, ( , takes the value zero or one determining whether branch is either excluded from or included in the model, respectively, and each antigenic effect, ( , represents the antigenic effect of a specific branch when it is included ( ( = 1).

When ( is zero, any antigenic weight attributed to the branch is nullified (as the product, ( ( , is zero). A higher proportion of MCMC samples with ( = 1 indicates higher support in the data for an antigenic change mapping to branch . For each branch, the proportion of ( = 1, which is also the posterior mean value, ̅ ( , is referred to as the inclusion probability for the branch. This allows antigenic changes in the evolution of assayed viruses to be mapped to specific branches of the phylogeny to generate Ψ D = E ∈ Ψ: ̅ ( > J, the subset of those branches tested that are inferred to be potentially antigenically significant by having inclusion probability above some threshold, p. In previous work these phylogenetic variables were selected using a random restart hill-climbing algorithm that optimised Akaike information criterion (AIC) to reduce computation cost (12, 13) . However, we have subsequently shown that variable selection using these binary masks is a superior strategy (18) .

Incorporating amino acid substitutions. Next, terms were introduced to explicitly attribute antigenic differences between viruses to specific amino acid changes. The shared evolutionary history of the viruses has the potential to facilitate false statistical support for substitutions due to repeated measurements. To control for the evolutionary relationship between viruses and reduce this risk, Ψ D , the subset of phylogenetic terms identified as explaining antigenic variation using Eq 3, were retained in the new model. Branch variables were ranked by their inclusion probability ̅ ( and p, the threshold inclusion probability, was chosen so that the the proportion of branches from Ψ that were carried forward in Ψ D was M, the posterior mean inclusion probability of a branch.

The subsequent model then included all of these terms (to control for the shared evolutionary history of the viruses) together with terms representing amino acid positions:

Here, each amino acid position within the set of non-conserved positions Λ is indexed by , while all observed amino acid substitutions at each position are in turn indexed by . Each position was associated with a binary mask variable, -, that takes the value zero or one, as above, determining whether substitutions at position contribute to variation in titres. A precomputed indicator variable, ′ . ( , ), indicates whether or not each specific amino acid difference separates the reference and test viruses. Each antigenic effect, ′ . , represents the antigenic effect of a specific substitution.

Using the model described in Eq 4, antigenic effects of alternative substitutions at the same amino acid position are independent. An alternative model where the antigenic effects of different substitutions at the same position are linked is also explored:

The key difference here from Eq 4 is that the antigenic effect of a substitution is partitioned into a positionspecific component, S -, and a substitution-specific component, S′ . . The position-specific component is shared by every substitution observed at an amino acid position. This reflects an expectation that a range of substitutions at more antigenically important positions will tend to have greater antigenic impacts than at other positions. The substitution-specific component, on the other hand, allows for variability in the antigenic impact of alternative substitutions at the same position.

Incorporating structural information. Eqs 4 and 5, above, describe how variation in titres was attributed to antigenic effects of amino acid substitutions in what we term 'structurally-naïve' models. We now incorporate information from analysis of 3-D protein structure into the above models by using it to inform the prior probability that substitutions at an amino acid position are involved in antigenic evolution (by influencing the binary mask variable associated with each position). We implement this approach using two structural features: proximity to the receptor-binding site (RBS), and a predicted epitope score derived from a tool used to predict conformational epitopes from tertiary protein structure (see Materials and Methods). However, this approach is not limited to the use of these features and could be adapted to either a single or more than two structural features. Here, we refer to the two structural features as 2 and ! .

In Eqs 4 and 5 (the structurally-naïve models), the binary mask terms associated with each amino acid position, -, share a common prior distribution and therefore are equally likely to be included in the model prior to observation of the data. Here, the structurally-aware version of the models described above retain the structure described in Eqs 4 and 5. The only difference is that the binary mask variable Uis redefined so that the probability of each position being selected may be influenced by structural features 2,-and !,-:

To model the genetic basis of antigenic differences between influenza viruses, we first compiled antigenic (HI) and HA genetic sequence data from A(H3N2) viruses isolated during the period 1990-2014, and used the sequence data to construct a phylogeny describing the evolutionary relationships between viruses. Next, we mapped variation in HI titres to branches of the phylogenetic tree -BSSVS was used to identify branches of the phylogeny representing amino acid substitutions causing antigenic change and to quantify the associated degree of antigenic change. Specifically, we calculated the proportion of MCMC samples in which a phylogenetic variable from Eq 3 is selected (where the associated binary mask variable, ( = 1), which represents confidence in the selected variable, and we also recorded a quantitative estimate of the antigenic change, ( (in log2 HI units), associated with the branch. with relatively few antigenic events of more than 1 log2 HI units. While the histogram shows branches with larger effects to be found in both the trunk and side branches, the rate of antigenic change was found to be considerably higher in the trunk. Rates of antigenic evolution in the trunk and side branches were calculated by summing antigenic weights ( ( ( ) and dividing by the sum of branch lengths measured in years of evolutionary time estimated using a molecular clock analysis implemented in BEAST (20, 21) . The rate of antigenic drift in the trunk lineage was estimated to be 0.73 log2 HI units per year (95% HPD, 0.67-0.78), compared with 0.05 log2 HI units per year in the rest of the tree (95% HPD, 0.04-0.06). Cumulative antigenic distance from the root was calculated across the phylogenetic tree by summing antigenic effects ( ( ( ) across each branch in a path between the root and every internal node and tip. This cumulative antigenic distance is represented in the horizontal dimension in the tree in Fig 1a. Linear regression of cumulative antigenic distance for each node and cumulative branch lengths estimated a rate of antigenic drift of 0.72 log2 HI units per year (Fig 1c) . This aligns very closely with a figure of 0.71 previously estimated for a dataset of A(H3N2) viruses from the period 1985-2015 using a comparable approach (8). Genetic determinants of antigenic change. Next, amino acid substitutions were tested as predictors of reduced HI titres. Antigenic weights were estimated for each substitution with binary mask variables ( -) dictating whether substitutions at a particular position were included in the genetic model of variation in titres. Based on the HI data, for each variable position the posterior mean value of -, or the posterior inclusion probability, is the inferred probability that substitutions at position have contributed to antigenic evolution. To assess how well each model did in terms of attributing antigenic changes to amino acid substitutions, we examined posterior inclusion probabilities associated with amino acid positions in the context of antigenic sites defined in the literature. While the important antigenic areas of HA are known, definitions of the constituents and boundaries of the antigenic sites vary, making a binary in-or-out classification to assess model selection problematic. For this reason, we considered the distance in 3-D space from each residue to these sites rather than a binary in-or-out classification. These distances were calculated between alpha carbons, therefore were relatively insensitive to the changes in protein structure occurring during evolution. For example, distances calculated using the HA structures of A/Aichi/2/68 and A/Brisbane/10/2007 were highly correlated (R 2 >0.99, Fig S1a) , despite the two viruses being separated by 39 years of evolution. At each step of the MCMC, the mean distance to an antigenic site, averaged across the set of positions selected by the model ( -= 1) at that step, was calculated. The mean distance to antigenic site averaged over the MCMC chain was used to evaluate model performance with lower values indicating higher ability to correctly attribute antigenic variation to causative substitutions. Initial comparison of structurally-naïve models showed that a model assuming a link between the antigenic impact of subsitutions occurring at the same HA position (antigenic relationships, Δ ",$ , modelled using Eq 5) outperformed a simpler model that assumed no such link (Δ ",$ modelled using Eq 4) as indicated by a lower mean distance to antigenic sites of amino acid residues inferred to have substitutions explaining antigenic differences ( Table 2) . Using a single effect size ( ′ . in Eq 4 or S 1 . in Eq 5) for forward and reverse substitutions (symmetric substitution effects) also led to better model performance compared with estimating two effect sizes (asymmetric substitution). For the best performing structurally-naïve model (described by Inclusion probability axis, representing residues in described antigenic sites, have been adjusted in both dimensions to allow visualisation of overlapping points. A red line indicates the mean distance of residues selected with inclusion probability equal to or higher than that on the y-axis. A dashed vertical line at 8Å marks a threshold at which a position is approximately two residues away from an amino acid in a described antigenic site.

Incorporating structural data. To investigate whether incorporating data on protein structure could assist the accuracy with which variables explaining antigenic differences could be identified, the locations of residues within the HA structure were used to influence the inclusion probabilities estimated for each position. Two structural features were considered, the distance from the RBS and a structure-based epitope score which estimates how accessible areas of a protein are to an antibody. For each residue, its distance to the RBS was calculated as minimum distance in 3-D space of its alpha carbon to the closest alpha carbon of a RBS residue. A structure-based epitope score was calculated for each HA residue using BEpro (23) and reflects how exposed and accessible for antibody binding, the region centred on each residue is. Fig S1b-c) . Therefore, mean distance from the RBS and epitope scores averaged over the four structures (Fig 3) were considered suitable for use in modelling. Variation around the slope is expected as other factors such as the side-chain properties of the actual amino acid substitutions must contribute to determine whether positions influence antigenicity, however the slope of close to 1 indicates that the relationship between structure-informed probability and posterior inclusion probability is fitted correctly. In Figs 4d-e, HA positions are again placed according to structure-based epitope scores and distance from the RBS. Each non-conserved HA position is coloured by its posterior inclusion probability, the confidence that substitutions at the position have impacted antigenic evolution, in models fitted without (Fig 4d) and with structural data (Fig 4e) . The effect of structural information guiding variable selection is clear with residues positioned in the bottom right corner of the scatterplot for the structurally-aware model tending to be associated with higher inclusion probabilities, which corresponds to a greater number of red residues in surface-exposed areas near to the RBS in Fig 4e  compared with Fig 4d. Notably, a higher proportion of positions with an inclusion probability of one are identified using the structurally-aware model (Fig 4f compared with Fig 2a) . Table 2 ). Each of the 18 residues with the highest inclusion probability belonged to defined antigenic sites or were within 8Å of these and only position 183, at 8.9Å, was further away and associated with an inclusion probability of >0.5. Of all positions associated with an inclusion probability of >0.05, position 43, 19.3Å away, with an inclusion probability of 0.08, was the most distant. For comparison, 19 positions further than 19.3Å from antigenic sites were associated with inclusion probabilities of at least 0.05 using the structurally-naïve model (Fig 2c) , up to a maximum of 75.7Å (position 4, inclusion probability of 0.23).

The full dataset was comprised of 38,757 titres which included 3,477 different virus and reference antiserum combinations. These combinations were measured with 1,737 different viruses (including reference viruses) and antisera raised to 151 reference viruses. To assess the predictive performance of genetic models of antigenic phenotype, a range of model variants were tested for their capacity to recover HI titres under two prediction schemes. Firstly, to assess the capacity of models to predict unobserved antigenic relationships, 10% of virus and reference antiserum combinations (348 combinations), were randomly selected 100 times, and all titres associated with those combinations were removed to act as test data. Models were trained using the remaining 90% of virus and reference antiserum combinations and tested for their ability to accurately predict the removed titres. Secondly, to evaluate model capacity to predict titres of uncharacterised viruses, 10% of viruses (174 viruses) were randomly selected 100 times, and all titres for these viruses measured using any antiserum were removed to act as test data with data for the remaining 90% of viruses used to train models. Under both prediction schemes, the models (Eqs 3-6) included indicator variables to determine whether a genetic variable contributed to differences in titres, in common with the previous sections. As these indicator variables are present, the combination of HA positions at which substitutions contribute to predictions may vary at each step of the MCMC. This therefore constitutes prediction by model averaging rather than prediction conditioned on a single best model, accounting for uncertainty in the identification of the substitutions that cause antigenic differences.

Employing the first scheme, titres were predicted initially with the antigenic component of titres, Δ ",$ , modelled using the phylogenetic model described by Eq 3, with information on the antigenic changes associated with branches of the phylogeny ( ( ( ) estimated using the training data only. This model provides a reasonable approximation of antigenic relationships, allowing titres to be predicted for unknown virus and reference strain combinations under cross-validation with a mean absolute error (MAE) of 0.60 log2 HI units (root-mean-square deviation RMSD = 0.83, Table 3 , scheme 1). However, as the antigenic weights ( ( ( ) associated with branches are purely additive, the tree model fails to account for the antigenic consequences of phenomena such as reverse substitutions or the presence of the same substitution in multiple branches.

To account for these non-additive antigenic events requires terms that explicitly describe the presence or absence of amino acid substitutions (Δ ",$ modelled using Eq 4, 5 or 6). Using a model with independently estimated effect sizes for every substitution at each position (Eq 4) resulted in more accurate predictions with a MAE of 0.53 log2 HI units and RMSD of 0.69 ( Table 3 , scheme 1). Having the effects of substitutions at the same position linked (Eq 5) resulted in a marginal improvement in predictions (MAE = 0.52 and RMSD = 0.68) ( Table 3 , scheme 1). Improved predictions are expected under these substitution models, as they can account for convergent substitutions and reversions of substitutions. Using the structurally-aware model of antigenic relationships (Eq 6) resulted in similar prediction accuracy when predicting missing testreference virus combinations (MAE = 0.52 and RMSD = 0.69, Table 3 , scheme 1). The accuracy of these predictions are comparable to existing models for prediction of A(H3N2) HI titres (8) . This indicates that our efforts to increase the stringency of variable selection, rather than prioritising the selection of the maximally predictive set of genetic terms, do not hamper the predictive ability of our approach. Under the best performing genetic model, 87% of predictions were made within 1 log2 HI unit of the observed titre and 99% within 2 log2 HI units ( Table 3) . Under the second scheme, titres were predicted for 10% of viruses that had all titres removed to act as test data. The accuracy of all models was reduced under this prediction scheme ( Table 3 , scheme 2) with a MAE of only 1.13 log2 HI units (RMSD = 1.14) using the phylogenetic model. Predicting titres for viruses that are entirely absent from the training data is more challenging, in part, as it is not possible to estimate a virus avidity parameter ( $ in Eq 2), as recognised previously (8, 12) . The accuracy of predictions was improved using the substitution-based models (MAE 0.77-0.81 log2 HI units and RMSD = 1.01-1.05). Interestingly, the structurally-aware model is slightly better performing here when predicting for cross-validation test datasets consisting of missing test viruses (0.77 compared with 0.79, Table 3 , scheme 2). This indicates that more accurately attributing antigenic variation to the correct substitutions also offers an advantage when predicting antigenic relationships from HA sequences for viruses with no associated antigenic data.

In Fig 5a, titres predicted using scheme 1 are plotted against observed titres for the model with structural information (Eq 6). In Fig 5b, titres predicted using scheme 2 are plotted against the observed titres using the same model . Fig 5a shows a 

shows that in the absence of any information on the reactivity of a virus with any available antisera, there is a trend towards under-estimation of high observed titres. Such high titres tend to be associated with test viruses having higher than average titres across panels of antisera against which they are tested. Without information on these viruses (scheme 2), we observe a mean underestimation (predicted v observed) of -0.16 (Fig 5b) , which compares with a corresponding value of -0.06 for scheme 1 (Fig 5a) . 

Here, we describe an approach for identifying genetic changes that explain the antigenic drift of a rapidly evolving virus pathogen. The evolutionary process results in highly correlated genetic signals which can prove challenging for accurate mapping of genotype to antigenic phenotype. We describe a Bayesian approach whereby the causative amino acid changes are identified using BSSVS, performed alongside model fitting. increasing the tendency for the model to attribute antigenic variation to substitutions at HA positions within or nearby recognised antigenic sites (reducing the mean distance across samples from 6.86 Å to 2.55 Å). Cross-validation demonstrates that this approach can additionally provide accurate predictions of antigenic phenotype from HA gene sequence.

The evolutionary process by which viruses are derived can result in multiple mutations occurring at the same (or almost the same) location in the phylogeny. When multiple amino acid substitutions result and these occur together at a point where antigenic change occurs, there is uncertainty as to which substitution(s) have caused the antigenic change. Information on the antigenic consequences of the same substitutions occurring in other branches of the phylogeny or other substitutions at the same amino acid positions can be used to resolve these ambiguities in some cases, but often uncertainty remains and it may be impossible to define a single definitive set of causative genetic changes by statistical means. A benefit of a Bayesian approach with indicator variables is is that this explicitly accounts for uncertainty in the identification of causative amino acid substitutions and reflects this uncertainty in variable selection. A further advantage of a Bayesian approach in this context is the opportunity to include prior information on the antigenicity of HA, here in the form of structural data; something we show can help to further resolve ambiguities in model selection. Model uncertainty was continued into cross-validation with predictions of masked titres made using Bayesian model averaging over several models weighted by the posterior probability of each model given the data, rather than a single model with a single set of causative amino acid substitutions.

We describe an approach to integrate data on proximity to the RBS and a pre-computed structure-based epitope score into priors for the probability that substitutions at a position impact antigenicity, an approach that could be easily extended to other proteins or structural features. In this analysis of the influenza HA, a prior expectation that antigenically important substitutions would tend to occur at HA positions both increased proximity to the RBS and higher epitope scores was implemented through choice of priors. However the model was free to minimise the influence of either parameter and this approach is not limited to situations in which prior knowledge of the directionality of a relationship exists. An extension of this work would be to account for the shielding of epitopes by covalently attached glycans and the changes in the accessibility of epitopes that occurs as a result of changes in glycosylation over time (24, 25) . Our analysis was focused on the HA protein as the HI assay measures antigenic variation in HA. However, the analysis could be extended to also include neuraminidase to test for an antigenic effect of substitutions in that glycoprotein which may influence VN assays. There is also scope to exploit the transfer of information from data-rich to data-starved virus subtypes. For example, the relationship between structural features and the role in antigenic evolution could be trained using a data-rich subtype such as A(H3N2); this could inform the prior distributions for the inclusion probabilities of structurally-aligned positions in any newly emerged subtype that would have fewer available data.

Having developed the genetic model of antigenicity to fit known data, its predictive power was evaluated by cross-validation. Notably, we tested our methods by removing 10% of samples from the full dataset and used the remaining 90% of the data as the training set. This was done in two ways. The first was to remove 10% of virus and antiserum combinations, leaving other antigenic data for a particular virus in the training dataset. In this scheme (scheme 1) we saw that we could estimate as much as 87% of titres within 1 log2 HI unit of the observed titre and 100% within 2 log2 HI units and Fig 5a shows accuracy across all values of observed titre. This would mean, for example, that if we knew some of the characteristics of a test virus we could accurately estimate its HI titre against a new reference antiserum, a vaccine virus antiserum or a candidate vaccine virus antiserum within a two-fold dilution in most cases. The accuracy of the prediction was improved by the inclusion of variables representing amino acid substitutions (Eqs 4-6) over the basal phylogenetic model (Eq 3) which, lacking terms representing specific amino acid differences, cannot recognise when clades separated on the tree are antigenically similar because they share substitutions occurring convergently in different branches. Predictions were not markedly enhanced by linking the magnitude of antigenic effects caused by different amino acid substitutions occurring at the same HA position (Eq 5), or by the inclusion of structural information to guide the identification of the substitutions (Eq 6).

In the second, more challenging, assessment of the methods we removed all antigenic data for a virus and predicted its titres against reference antisera. Here, predictions were somewhat less accurate though up to 71% of predicted titres were within 1 log2 HI unit of the observed titre and 94% within 2 log2 HI units. In this prediction scheme (scheme 2) shown in Fig 5b, it is clear that the model rarely predicts high HI titres (e.g. >1280) with no knowledge of whether the 'missing' test virus has an inherent ability to be more sensitive to specific or non-specific inhibition by antisera. This result would, in the absence of any established antigenic data, predict whether an unknown virus was not well recognised by an antiserum (recognition of the test virus by antisera raised against reference viruses at titres 4-fold lower than the titre with the homologous virus) or was poorly recognised by such antisera (recognition at titres >4-fold lower than the homologous titres). Again, the greatest enhancement was, as seen in scheme 1, due to the inclusion of specific amino acid substitutions over and above the basal phylogenetic model. However, in scheme 2, the accuracy of the predictions improved, first by inclusion of specific amino acid substitutions (Eq 4), then by linkage of antigenic weights of alternative substitutions at a position (Eq 5), and finally by including information on the proximity of residues to the RBS and structure-based epitope scores (Eq 6).

In summary, the ability to predict antigenic cross-reactivity of emerging influenza viruses, as measured by HI, while maximising identification of the causative amino acid substitutions provides important information with which to evaluate the epidemic potential of influenza virus variants. Using models parameterised using data collected in previous years can help to refine such techniques and we describe how structural data can be incorporated into model fitting. Incorporating other sources of prior information is an exciting area for further model development, for example alternative protein structural data could be tested as explaining variation in alternative assays used to characterise antigenic similarity of viruses. The benefits of being able to integrate such data types into modelling of evolution could be particularly powerful when performing analyses of emerging influenza viruses for which historic data are unavailable. The approach we describe, allowing detailed and accurate mapping of genotype to antigenic phenotype, should progress efforts to understand the genetic determinants of virus fitness and evolutionary trajectories of influenza viruses, importantly when surveillance is increasingly based on a 'sequence-first' approach. Moreover, this approach could also be adapted to proteins of other viruses such as the capsid proteins of foot-and-mouth disease virus and the spike protein of coronaviruses.

Influenza data. Influenza viruses were originally isolated from clinical specimens either by WHO National Influenza Centres or by the London-based WHO Collaborating Centre (CC). The antigenic dataset for A(H3N2) included 1737 viruses for which HI and HA1-encoding gene sequence data were generated at the CC. All HI data used were from assays carried out at the CC and were obtained using post-infection ferret antisera. The data associated with this study are available online (26) . HA1 nucleotide sequences and collection dates were analysed to generate temporal phylogenies using BEAST v1.8.2 (27) . Phylogenies were estimated using a variety of nucleotide substitution, demographic, and molecular clock models. A general time reversible model of nucleotide substitution with proportion of invariant sites and a gamma distribution with four categories describing among-site variation (GTR + I + Γ4) was determined to be the most suitable model by comparison of Bayes factors. The trunk lineage was defined from the root through the descendant node leading to the greater number of sampled viruses.

For each residue in the structure, the distance from the RBS was calculated as the minimum distance in 3-D space between the alpha carbon of that residue and the nearest alpha carbon of a residue in the RBS (positions 98, 135, 136, 153, 183, 190, 194, 195, 225, 226 , and 228) (28) . The distance of each HA residue to the nearest antigenic site constituent was calculated as the minimum distance in 3-D space from the residue's alpha carbon to the nearest alpha carbon of a residue in the antigenic site A (positions 124, 126, 128, 131, 133, 135, 137, 142, 143, 144, 145, and 146), site B (155, 156, 157, 158, 159, 160, 163, 164, 186, 188, 189, 190, 192, 193, 196, 197, 198 and 199) (22, 29, 30) . To determine structure-based epitope scores for each residue in the HA structure from tertiary structure, the program BEpro (23) Model Implementation. The Modelling Approach section above describes the modelling process by which variation in HI titres was attributed to genetic differences between viruses while accounting for phylogenetic relationships and non-antigenic sources of variation in titres using a hierarchical model structure. The terms used in the models are described in Table 1 . This section describes choices of prior and other implementation details. Models were fitted in JAGS v4.3.0 (34) using the R package runjags v2.0.4-6 (35). Post-infection ferret antisera were raised to a range of reference viruses ( ) and HI titres measured for an individual antiserum and several viruses ( ) (including the homologous titre to the corresponding reference virus and a range of other viruses). The measured titre for antiserum against reference virus and virus on a given date , ",$,% was modelled as an underlying titre for the combination of reference virus and test virus pair, ",$ , and an effect for date along with a variance term (Eq 1). To reflect a lack of prior information, the effect for date was implemented with a diffuse prior for the effect of date defined as a normal distribution where %~N ormal(0, σ 4 ! ) with the variance parameter σ 4 ! was drawn from an inverse gamma distribution such that σ 4 !~I nverse Gamma(0.001, 0.001). The variance term accounting for residual variation in measured titres was drawn from the prior distribution σ & !~I nverse Gamma(0.001, 0.001). The underlying titre for each test virus and reference strain was modelled according to a general structure described by Eq 2. Priors for the estimated impact on titres associated with the use of antiserum raised using each reference virus were defined as "~N ormal( 5 , 5 ! ).

Here, the mean was given the prior 5~N ormal( 678 , 9 $ ! ) where 678 was the maximum observed titre and 9 $ ! = 1.5 to maintain a value for the intercept proximal to the range of possible recorded titres without explicitly enforcing a particular value such as the maximum observed titre within the dataset and The antigenic component of the model described in Eq 3, Δ ",$ , estimates the drop in HI titres caused by the antigenic dissimilarity of reference strain and test virus . Δ ",$ was modelled in several ways (Eqs 3-6) though was restricted to be positive throughout and was always subtracted from the other terms contributing to variation in titres (Eq 3). Using the combination of branches of the phylogenetic tree traversed when a path between them is drawn through the tree (Eq 3), each branch, , of the phylogenetic tree, Ψ, was associated with a binary mask term, ( , that determined whether the branch was included in the model or not and an antigenic weight parameter, ( , representing the estimated drop in HI titres due to antigenic change mapping to the branch. These antigenic weights were required to be non-negative and the prior was defined as (~ Gamma(2, 1) . This choice of prior distribution discouraged the inclusion in the model of a high number of branches associated with very small antigenic weights, on the basis that effects very close to zero cannot be identified in HI assay data, thereby encouraging a more parsimonious model. Binary mask variables associated with each branch were drawn from a Bernoulli trial defined as (~B ernoulli( ) where was given the prior ~Beta (2, 8) to favour a sparse model reflecting the expectation that a relatively low proportion of branches were expected to represent genetic differences influencing titres. The posterior mean value of determined the proportion of branches used to account for phylogenetic structure when testing variables representing specific amino acid differences (Eqs 4, 5 and 6).

Next, terms were introduced to explicitly attribute antigenic differences between viruses expressed in HI assays to specific amino acid differences (Eq 4). These terms representing specific amino acid difference were tested in the presence of a subset of phylogenetic terms selected using Eq 3, Ψ D . Each amino acid position was associated with a binary mask term, -, for which the prior was specified as -~B ernoulli( 1 ) where given the prior 1~B eta (2, 8) mirroring that used for the binary mask associated with phylogenetic terms above. When implementing Eq 4, priors for the effect sizes associated with substitutions were specified as ′ .~ Gamma(1, 1), which allows for antigenic effects close to zeronecessary as this allows for substitutions that do not affect antigenic cross-reactivity to occur at amino acid positions included in the model due to the presence of other antigenically important substitutions at the position. A similar model where substitutions occurring at the same amino acid position are linked in their effect size is described by Eq 5, which differs from Eq 4 by having the antigenic effect of a substitution partitioned into position-specific and substitution-specific componenets, Sand S ′ . respectively. Priors for the position-specific antigenic parameter were specified as S -~ Gamma(2, 1), discouraging near-zero antigenic effects at the position level. Eq 5 was implemented with the prior for specific amino acid substitutions specified as S′ .~G amma(α, α) where α~Gamma(2, 1). This allows for a range of small and large antigenic impacts and, but the mean of this prior is equal to 1 regardless of the value of α. Therefore, for rarer substitutions (ones informed by very few titres) where the data make reliable estimation of an effect size unlikely, S′ . tends towards 1, so the antigenic impact of the substitution will be largely determined by the value estimated for the position-specific antigenic effect S -.

Structural data associated with each amino acid position were used to influence the probability that substitutions at that position contribute to antigenic evolution as apparent in HI titres (Eqs 7 and 8) . The binary mask term for each position, U -, now depends on a position-specific structure-based probability of antigenic importance [ -. Two features derived from structural analysis of published H3 HA structures, as described above, were defined for each HA position: the distance from the RBS, 2 , and a structure-based epitope score, ! (see Structural analysis section). Each of these were re-scaled between zero and one prior to modelling so that higher values reflected high proximity to the RBS and high epitope scores respectively. Whether or not substitutions at an HA position contributed to variation in HI titres depended on the outcome of a Bernouilli trial where for each position, , a structure-informed probability [ -was determined as the product of 2,-and !,-. Higher values of each structural feature were expected to increase the probability that a position was antigenically important and so the parameters 1 and 2 were restricted to be positive and their priors were defined as 2~ Gamma(1, 1) and !~ Gamma(1, 1).

Two cross-validation schemes were performed with the full dataset repeatedly divided into training and test datasets at random, criteria for each are described in the Results section. Under each scheme, measurements for antisera not present in the training data were excluded from the test dataset. Models described by Eqs 3-6 were each fitted to the training data and used to predict HI titres for virus and antiserum combinations present in the test data. Predicted titres were compared with observed titres, with both MAE and RMSD calculated. Each error influences MAE in direct proportion to the absolute value of the error whereas RMSD placing more emphasis on penalisation of higher errors. distance of residues selected with inclusion probability equal to or higher than that on the y-axis while a dotted red line shows the corresponding line from a structurally-naïve model shown in Fig 2c. A dashed vertical line at 8Å marks a threshold at which a position is approximately two residues away from an amino acid in the described antigenic site. 

Influenza (seasonal) fact sheet

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

Reflections on The Global Influenza Surveillance and Response System (GISRS) at 65 Years: An Expanding Framework for Influenza Detection, Prevention and Control

The Global Influenza Surveillance and Response System (GISRS) -A Future Perspective

Predictive Modeling of Influenza Shows the Promise of

Predicting evolution from the shape of genealogical trees

A predictive fitness model for influenza

Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses

Mapping the antigenic and genetic evolution of influenza virus

Integrating influenza antigenic dynamics with molecular evolution

Using sequence data to infer the antigenicity of influenza virus

Identification of Low-and High-Impact Hemagglutinin Amino Acid Substitutions That Drive Antigenic Drift of Influenza A(H1N1) Viruses

Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus

The molecular basis of antigenic variation among A(H9N2) avian influenza viruses

A sparse hierarchical Bayesian model for detecting relevant antigenic sites in virus evolution

Regression shrinkage and selection via the lasso

Regularization and variable selection via the elastic net

Improving the identification of antigenic sites in the H1N1 influenza virus through accounting for the experimental structure in a sparse hierarchical Bayesian model

Bayesian model averaging

Relaxed phylogenetics and dating with confidence

Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10

The structure and function of the hemagglutinin membrane glycoprotein of influenza virus

Improved discontinuous B-cell epitope prediction using multiple distance thresholds and half sphere exposure

Changing selective pressure during antigenic changes in human influenza H3

Human influenza a virus hemagglutinin glycan evolution follows a temporal pattern to a glycan limit

Human seasonal influenza A(H3N2) haemagglutinin inhibition data from 1990-2014 from the WHO Collaborating Centre for Reference and Research on Influenza

Bayesian phylogenetics with BEAUti and the BEAST 1.7

Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

Structural basis of immune recognition of influenza virus hemagglutinin

Evolution of the receptor binding properties of the influenza A (H3N2) hemagglutinin

A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine

Refinement of the influenza virus hemagglutinin by simulated annealing

Just Another Gibbs Sampler v3.3.0 (JAGS): A program for analysis of Bayesian graphical models using Gibbs sampling

runjags : An R Package Providing Interface Utilities , Model Templates , Parallel Computing Methods and Additional Distributions For MCMC Models in JAGS